Welcome to LookChem.com Sign In|Join Free

CAS

  • or

41575-87-5

Post Buying Request

41575-87-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41575-87-5 Usage

Description

Diamminebis(nitrato-O)platinum, also known as platinum diammine complexes, is a platinum-based compound with significant applications in the medical field. It is a pale yellow solid that has been extensively studied for its potential in treating various types of cancer.

Uses

Used in Anticancer Applications:
Diamminebis(nitrato-O)platinum is used as an anticancer agent for brain tumors. It has demonstrated cytotoxic activity against cancer cells, making it a promising candidate for the treatment of brain tumors.
Used in Drug Delivery Systems:
Diamminebis(nitrato-O)platinum is also used in the development of drug delivery systems. The synthesis and cytotoxic activity of platinum complexes immobilized by branched polyethylene glycol have been explored to enhance the delivery, bioavailability, and therapeutic outcomes of this platinum-based compound. This approach aims to improve the efficacy of diamminebis(nitrato-O)platinum in treating brain tumors and potentially other types of cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 41575-87-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,5,7 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 41575-87:
(7*4)+(6*1)+(5*5)+(4*7)+(3*5)+(2*8)+(1*7)=125
125 % 10 = 5
So 41575-87-5 is a valid CAS Registry Number.
InChI:InChI=1/2NO3.2H3N.Pt/c2*2-1(3)4;;;/h;;2*1H3;/q2*-1;;;+2

41575-87-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Platinum(2+) nitrate ammoniate (1:2:2)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41575-87-5 SDS

41575-87-5Relevant articles and documents

Combating metastasis of breast cancer cells with a carboplatin analogue containing an all-trans retinoic acid ligand

Cheng, Junjie,Dai, Yi,Huang, Hai,Liu, Yangzhong,Shen, Ai-Zong,Zhu, Yang

supporting information, p. 5039 - 5043 (2020/05/08)

Pt-ATRA, a carboplatin analogue containing an all-trans retinoic acid (ATRA) derivative ligand, was synthesized via a click reaction. Upon cellular internalization, Pt-ATRA exhibits a dual function, releasing an active Pt(ii) moiety to induce cell apoptosis and ATRA to inhibit tumor metastasis.

Synthesis, characterization, structures and cytotoxicity of platinum(II) complexes containing dimethylpyrazole based selenium ligands

Chopade, Suresh M.,Phadnis, Prasad P.,Hodage, Ananda S.,Wadawale, Amey,Jain, Vimal K.

supporting information, p. 72 - 80 (2015/02/19)

A series of water soluble platinum(II) complexes of general formulae [Pt(en)(L)][NO3]2, [Pt(NH3)2(L)][NO3]2 [en = ethylenediamine; L = dmpzC6H4Se(CH2)nCOOH or dmpzCH2CH2Se(CH2)nCOOH (n = 1 and 2)], [Pt(en)(L)][NO3][OH]·H2O [L = dmpzCH2CH2Se(CH2)nCOOH (n = 1 and 2)] and [Pt(dmpzCH2CH2SeCH2CH2COOH)2][Cl]2·2H2O have been synthesized. They were characterized by microanalyses, IR, NMR (1H, 13C{1H}, 77Se{1H} and 195Pt{1H}) spectroscopy. Molecular structures of [Pt(en)(dmpzCH2CH2SeCH2COOH)][NO3][OH]·H2O and [Pt(dmpzCH2CH2SeCH2CH2COOH)2][Cl]2·2H2O were determined unambiguously by single crystal X-ray diffraction analyses. The cytotoxicity of these complexes has been evaluated against human colon (HT29, Colo205), ovarian (A2780) and bladder (T24) cancer cell lines and compared with the activity of cisplatin and adriamycin.

PARTUCULATE CONSTRUCTS FOR RELEASE OF ACTIVE AGENTS

-

Page/Page column 39, (2008/06/13)

Particulate constructs stabilized by amphiphilic copolymers and comprising at least one active coupled to a hydrophobic moiety provide sustained release of the active in both in vitro and in vivo environments.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 41575-87-5